APA Citation

Hujber, Z., Petővári, G., Szoboszlai, N., Dankó, T., Nagy, N., Kriston, C., . . . Sebestyén, A. (2017). Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. J Exp Clin Cancer Res.

Citação norma Chicago

Hujber, Zoltán, et al. "Rapamycin (mTORC1 Inhibitor) Reduces the Production of Lactate and 2-hydroxyglutarate Oncometabolites in IDH1 Mutant Fibrosarcoma Cells." J Exp Clin Cancer Res 2017.

MLA Citation

Hujber, Zoltán, et al. "Rapamycin (mTORC1 Inhibitor) Reduces the Production of Lactate and 2-hydroxyglutarate Oncometabolites in IDH1 Mutant Fibrosarcoma Cells." J Exp Clin Cancer Res 2017.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.